October 7, 2021
You have a patient with a penicillin allergy documented in their chart. Typically, you would prescribe amoxicillin for their infection, but that is not an option because it is a penicillin-class antibiotic. Instead, you prescribe a broader-spectrum antibiotic–not your first choice except for the allergy. But, what if you learned that it is not a true allergy?
September 28, 2021
UNC School of Medicine, the World Health Organization, and the Ethiopian Public Health Institute conducted a joint study to find that malaria parasites are spreading undetected across the Horn of Africa, posing a major health threat to the region. Lead UNC lead investigator Jonathan Parr, MD, MPH, is senior author of this Nature Microbiology paper.
September 14, 2021
With a majority of kids back at daycare and in classrooms, Zach Willis, MD, MPH, and Bill Wilson, PharmD, expect to see a comeback in pediatric community-acquired pneumonia. A new clinical pathway is hoped to aid provider decision-making for these young patients.
September 1, 2021
Register for our annual IHQI Symposium to celebrate the hard work and success of our Improvement Scholars. The Symposium will feature presentations from six clinician-led improvement initiatives.
August 18, 2021
A study in Lancet Global Health led by UNC School of Medicine’s Peyton Thompson, MD, MSCR and Jonathan Parr, MD, MPH showed the feasibility and acceptance of hepatitis B virus testing, treatment, and vaccination programs in the Democratic Republic of the Congo.
August 5, 2021
The Doris Duke Charitable Foundation has selected Ross Boyce, MD, as a recipient of a 2021 Clinical Scientist Development Award for his research proposal titled, “Getting malaria off the back of women and children in western Uganda.”
June 23, 2021
UNC School of Medicine scientists led by Aravinda de Silva, PhD, identified the small subpopulation of antibodies in vaccinated children that correlate with protection against dengue fever. This research should help shape better vaccines for one of the most widespread infectious diseases in the world.
June 23, 2021
Nadja Vielot, PhD, assistant professor of Family Medicine was recently awarded a diversity supplement sponsored by the NIH National Center for Advancing Translational Sciences (NCATS) to conduct a study of the effectiveness of the recombinant herpes zoster vaccine among older adults using health care utilization data.
June 9, 2021
The National Institute on Minority Health and Health Disparities (NIMHD) recently awarded five research grants to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities.
May 13, 2021
Research contributing to discoveries associated with COVID-19 has been growing on the UNC campus over the past year. To help increase visibility of this integral research and illustrate the extensive organizational collaborations that help move UNC research forward, a team from University Libraries – Health Sciences Library analyzed the COVID-19 research output of UNC Chapel Hill (UNC-CH) researchers between January 2020 and April 2021.
May 5, 2021
UNC-Chapel Hill and Duke researchers promote better health through gamification. The study was co-led by Lisa Hightow-Weidman, MD, MPH, at the UNC School of Medicine, and Kate Meussig, Phd, at the UNC Gillings School of Global Public Health.
March 30, 2021
The tool kit was developed by Mildred Kwan, MD, PhD, and Renae Boerneke, PharmD, to educate patients and train healthcare providers to proactively assess penicillin allergies. Delabeling patients who are not truly allergic to penicillins is an important stewardship tool that decreases unnecessary use of broad-spectrum antibiotics.